Literature DB >> 1398994

Feedback suppression of staphylococcal enterotoxin-stimulated T-lymphocyte proliferation by macrophages through inductive nitric oxide synthesis.

K Isobe1, I Nakashima.   

Abstract

Staphylococcal enterotoxin A (SEA)- or SEB-stimulated T-lymphocyte proliferation was suppressed by the addition of high numbers of murine peritoneal macrophages or rat peritoneal or alveolar macrophages, whereas lower numbers of murine peritoneal macrophages enhanced the T-lymphocyte response. Suppression was associated with the increase of accumulation of nitrite, a product of nitric oxide, in the culture supernatants. This macrophage-mediated suppression was totally reversed by the addition of NG-monomethyl-L-arginine, a homolog of L-arginine, indicating that macrophage-mediated suppression of T-lymphocyte proliferation was mediated through the nitric oxide-synthesizing pathway activity. Macrophages in large numbers spontaneously produced nitric oxide in culture supernatant fluids. By the addition of autologous or allogeneic spleen cells but not thymocytes to SEA- or SEB-stimulated macrophage culture, nitric oxide production was greatly increased. When T lymphocytes in spleen cells were killed by antibody before addition to macrophage culture, nitric oxide production was diminished to the basal level. These results suggest that in addition to the action to support the process of T-lymphocyte activation by SEA or SEB, macrophages display a feedback regulatory action on the SEA- or SEB-stimulated T-cell proliferative response by releasing nitric oxide through interaction between macrophages and activated T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398994      PMCID: PMC258238          DOI: 10.1128/iai.60.11.4832-4837.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells.

Authors:  K Imanishi; H Igarashi; T Uchiyama
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

2.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

3.  Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.

Authors:  R G Knowles; M Palacios; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway.

Authors:  C D Mills
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

5.  Murine macrophage activation by staphylococcal exotoxins.

Authors:  S D Fleming; J J Iandolo; S K Chapes
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway.

Authors:  J E Albina; J A Abate; W L Henry
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

7.  The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice.

Authors:  J White; A Herman; A M Pullen; R Kubo; J W Kappler; P Marrack
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

8.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.

Authors:  J B Hibbs; R R Taintor; Z Vavrin
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

9.  Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.

Authors:  D J Stuehr; C F Nathan
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Suppression of in vitro cytotoxic response by macrophages due to induced arginase.

Authors:  J T Kung; S B Brooks; J P Jakway; L L Leonard; D W Talmage
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  7 in total

1.  Avian reovirus induces an inhibitory effect on lymphoproliferation in chickens.

Authors:  S Neelima; G C Ram; J M Kataria; T K Goswami
Journal:  Vet Res Commun       Date:  2003-01       Impact factor: 2.459

2.  A nitric oxide-releasing reagent, S-nitroso-N-acetylpenicillamine, enhances the expression of superoxide dismutases mRNA in the murine macrophage cell line RAW264-7.

Authors:  H Sano; M Hirai; H Saito; I Nakashima; K I Isobe
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

3.  Immunomodulatory properties of porins of some members of the family Enterobacteriaceae.

Authors:  V Alurkar; R Kamat
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophages.

Authors:  D Blond; H Raoul; R Le Grand; D Dormont
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.

Authors:  G J Dusting; K Akita; H Hickey; M Smith; V Gurevich
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

6.  Regulation of staphylococcal enterotoxin B-elicited nitric oxide production by endothelial cells.

Authors:  R D LeClaire; W M Kell; R A Sadik; M B Downs; G W Parker
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

7.  Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation.

Authors:  Jeroen F J Bogie; Piet Stinissen; Niels Hellings; Jerome J A Hendriks
Journal:  J Neuroinflammation       Date:  2011-07-25       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.